-
1
-
-
84884294190
-
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J AM Coll Cardiol 62 (2013), e147–e239.
-
(2013)
J AM Coll Cardiol
, vol.62
, pp. e147-e239
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
-
2
-
-
80055011831
-
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction
-
Januzzi, J.L. Jr., Rehman, S.U., Mohammed, A.A., et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 58 (2011), 1881–1889.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1881-1889
-
-
Januzzi, J.L.1
Rehman, S.U.2
Mohammed, A.A.3
-
3
-
-
34247866537
-
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure
-
Fonarow, G.C., Peacock, W.F., Phillips, C.O., et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49 (2007), 1943–1950.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1943-1950
-
-
Fonarow, G.C.1
Peacock, W.F.2
Phillips, C.O.3
-
4
-
-
70350512957
-
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
-
Cleland, J.G., McMurray, J.J., Kjekshus, J., et al. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 54 (2009), 1850–1859.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 1850-1859
-
-
Cleland, J.G.1
McMurray, J.J.2
Kjekshus, J.3
-
5
-
-
77956342970
-
Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure
-
Sachdeva, A., Horwich, T.B., Fonarow, G.C., Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol 106 (2010), 830–835.
-
(2010)
Am J Cardiol
, vol.106
, pp. 830-835
-
-
Sachdeva, A.1
Horwich, T.B.2
Fonarow, G.C.3
-
6
-
-
0037432301
-
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
-
Anand, I.S., Fisher, L.D., Chiang, Y.T., et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003), 1278–1283.
-
(2003)
Circulation
, vol.107
, pp. 1278-1283
-
-
Anand, I.S.1
Fisher, L.D.2
Chiang, Y.T.3
-
7
-
-
5644268954
-
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
-
Bettencourt, P., Azevedo, A., Pimenta, J., Frioes, F., Ferreira, S., Ferreira, A., N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004), 2168–2174.
-
(2004)
Circulation
, vol.110
, pp. 2168-2174
-
-
Bettencourt, P.1
Azevedo, A.2
Pimenta, J.3
Frioes, F.4
Ferreira, S.5
Ferreira, A.6
-
8
-
-
50949104678
-
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
-
Masson, S., Latini, R., Anand, I.S., et al. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 52 (2008), 997–1003.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 997-1003
-
-
Masson, S.1
Latini, R.2
Anand, I.S.3
-
9
-
-
84874465184
-
Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study
-
Weiner, R.B., Baggish, A.L., Chen-Tournoux, A., et al. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study. Eur J Heart Fail 15 (2013), 342–351.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 342-351
-
-
Weiner, R.B.1
Baggish, A.L.2
Chen-Tournoux, A.3
-
10
-
-
84908060979
-
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
-
Felker, G.M., Ahmad, T., Anstrom, K.J., et al. Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. J Am Coll Cardiol HF 2 (2014), 457–465.
-
(2014)
J Am Coll Cardiol HF
, vol.2
, pp. 457-465
-
-
Felker, G.M.1
Ahmad, T.2
Anstrom, K.J.3
-
11
-
-
85028365288
-
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: a randomized clinical trial
-
Felker, G.M., Anstrom, K.J., Adams, K.F., et al. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: a randomized clinical trial. JAMA 318 (2017), 713–720.
-
(2017)
JAMA
, vol.318
, pp. 713-720
-
-
Felker, G.M.1
Anstrom, K.J.2
Adams, K.F.3
-
12
-
-
67649085911
-
Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories
-
Douglas, P.S., DeCara, J.M., Devereux, R.B., et al. Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories. J Am Soc Echocardiogr 22 (2009), 755–765.
-
(2009)
J Am Soc Echocardiogr
, vol.22
, pp. 755-765
-
-
Douglas, P.S.1
DeCara, J.M.2
Devereux, R.B.3
-
13
-
-
84925515752
-
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
-
Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.
-
(2015)
J Am Soc Echocardiogr
, vol.28
, pp. 1-39
-
-
Lang, R.M.1
Badano, L.P.2
Mor-Avi, V.3
-
14
-
-
84982182159
-
Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
-
Nagueh, S.F., Smiseth, O.A., Appleton, C.P., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29 (2016), 277–314.
-
(2016)
J Am Soc Echocardiogr
, vol.29
, pp. 277-314
-
-
Nagueh, S.F.1
Smiseth, O.A.2
Appleton, C.P.3
-
15
-
-
0142008980
-
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography
-
Zoghbi, W.A., Enriquez-Sarano, M., Foster, E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003), 777–802.
-
(2003)
J Am Soc Echocardiogr
, vol.16
, pp. 777-802
-
-
Zoghbi, W.A.1
Enriquez-Sarano, M.2
Foster, E.3
-
16
-
-
76449120415
-
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
-
Berger, R., Moertl, D., Peter, S., et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 55 (2010), 645–653.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 645-653
-
-
Berger, R.1
Moertl, D.2
Peter, S.3
-
17
-
-
84902577748
-
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
-
Troughton, R.W., Frampton, C.M., Brunner-La Rocca, H.P., et al. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J 35 (2014), 1559–1567.
-
(2014)
Eur Heart J
, vol.35
, pp. 1559-1567
-
-
Troughton, R.W.1
Frampton, C.M.2
Brunner-La Rocca, H.P.3
-
18
-
-
85039164574
-
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction
-
Yancy, C.W., Januzzi, J.L. Jr., Allen, L.A., et al. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction. J Am Coll Cardiol 71 (2018), 201–230.
-
(2018)
J Am Coll Cardiol
, vol.71
, pp. 201-230
-
-
Yancy, C.W.1
Januzzi, J.L.2
Allen, L.A.3
-
19
-
-
66249125916
-
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
-
Kubanek, M., Goode, K.M., Lanska, V., Clark, A.L., Cleland, J.G., The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11 (2009), 367–377.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 367-377
-
-
Kubanek, M.1
Goode, K.M.2
Lanska, V.3
Clark, A.L.4
Cleland, J.G.5
-
20
-
-
77955293973
-
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach
-
Kramer, D.G., Trikalinos, T.A., Kent, D.M., Antonopoulos, G.V., Konstam, M.A., Udelson, J.E., Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol 56 (2010), 392–406.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 392-406
-
-
Kramer, D.G.1
Trikalinos, T.A.2
Kent, D.M.3
Antonopoulos, G.V.4
Konstam, M.A.5
Udelson, J.E.6
-
21
-
-
20144388239
-
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
-
Januzzi, J.L. Jr., Camargo, C.A., Anwaruddin, S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005), 948–954.
-
(2005)
Am J Cardiol
, vol.95
, pp. 948-954
-
-
Januzzi, J.L.1
Camargo, C.A.2
Anwaruddin, S.3
|